Anatomical, Physiological and Metabolic Changes with Gestational Age During Normal Pregnancy: A Database for Parameters Required in Physiologically-based Pharmacokinetic Modeling Publication Anatomical, Physiological and Metabolic Changes with Gestational Age During Normal Pregnancy: A Database for Parameters Required in Physiologically-based Pharmacokinetic Modeling Pregnancy is associated with considerable changes in the physiological, anatomical and biochemical attributes in women.…CertaraDecember 13, 2013
Bottom-up Modeling and Simulation of Tacrolimus Clearance: Prospective Investigation of Blood Cell Distribution, Sex and CYP3A5 Expression as Covariates and Assessment of Study Power Publication Bottom-up Modeling and Simulation of Tacrolimus Clearance: Prospective Investigation of Blood Cell Distribution, Sex and CYP3A5 Expression as Covariates and Assessment of Study Power The objectives were to investigate the ability of population-based in vitro-in vivo extrapolation (IVIVE) to…CertaraDecember 1, 2013
An Evaluation of the Pharmacokinetics of Treprostinil Diethanolamine in Subjects with Hepatic Impairment Publication An Evaluation of the Pharmacokinetics of Treprostinil Diethanolamine in Subjects with Hepatic Impairment Treprostinil diolamine (oral treprostinil) is a prostacyclin analogue under evaluation for the treatment for pulmonary…CertaraDecember 1, 2013
Modeling of Pharmacokinetic Systems Using Stochastic Deconvolution Publication Modeling of Pharmacokinetic Systems Using Stochastic Deconvolution In environments where complete mechanistic knowledge of the system dynamics is not available, a synergy…CertaraDecember 1, 2013
Differences in Cytochrome P450-mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically-based Pharmacokinetic Modeling Publication Differences in Cytochrome P450-mediated Pharmacokinetics Between Chinese and Caucasian Populations Predicted by Mechanistic Physiologically-based Pharmacokinetic Modeling International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)…CertaraDecember 1, 2013
Absence of Pharmacokinetic Drug-drug Interaction of Pertuzumab with Trastuzumab and Docetaxel Publication Absence of Pharmacokinetic Drug-drug Interaction of Pertuzumab with Trastuzumab and Docetaxel Pertuzumab is a novel antihuman epidermal growth factor receptor 2 (HER2) humanized monoclonal antibody. Combined…CertaraNovember 24, 2013
Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis On-Demand Webinar Phoenix WinNonlin: A State of the Art Software Tool for Pre-clinical PK and TK Analysis Are you currently using Excel for PK/TK analysis? Phoenix WinNonlin streamlines analyses and generates all…CertaraNovember 21, 2013
Introduction to Population PK/PD Analysis Using Phoenix NLME On-Demand Webinar Introduction to Population PK/PD Analysis Using Phoenix NLME Phoenix NLME provides sophisticated algorithms and powerful and flexible data processing and modeling tools for…CertaraNovember 14, 2013
Predicted Heart Rate Effect of Inhaled LABA PF-00610355 in Volunteers and COPD Patients Publication Predicted Heart Rate Effect of Inhaled LABA PF-00610355 in Volunteers and COPD Patients The aim of this study was to assess the cardiovascular effects of a new inhaled…CertaraNovember 1, 2013
Prediction of Overall Survival or Progression Free Survival by Disease Control Rate at Week 8 Is Independent of Ethnicity: Western Versus Chinese Patients with First-line Non-small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab Publication Prediction of Overall Survival or Progression Free Survival by Disease Control Rate at Week 8 Is Independent of Ethnicity: Western Versus Chinese Patients with First-line Non-small Cell Lung Cancer Treated with Chemotherapy with or without Bevacizumab Categorizations of best response observed at week 8 of first-line treatment in two studies of…CertaraOctober 22, 2013